Mackenzie Financial Corp Cuts Stock Holdings in CME Group Inc. (NASDAQ:CME)

Mackenzie Financial Corp reduced its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 6.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,151,866 shares of the financial services provider's stock after selling 76,074 shares during the period. Mackenzie Financial Corp owned 0.32% of CME Group worth $267,498,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Peak Retirement Planning Inc. purchased a new stake in shares of CME Group during the 4th quarter valued at $843,000. Parr Mcknight Wealth Management Group LLC bought a new position in CME Group during the fourth quarter valued at about $3,368,000. GTS Securities LLC grew its position in CME Group by 186.2% during the fourth quarter. GTS Securities LLC now owns 3,039 shares of the financial services provider's stock valued at $706,000 after buying an additional 6,566 shares during the period. Breed s Hill Capital LLC purchased a new stake in CME Group during the fourth quarter worth about $247,000. Finally, Vise Technologies Inc. raised its position in CME Group by 73.3% in the fourth quarter. Vise Technologies Inc. now owns 5,159 shares of the financial services provider's stock worth $1,198,000 after acquiring an additional 2,182 shares during the period. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. Raymond James raised CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 target price on the stock in a research note on Monday, March 10th. Morgan Stanley increased their price target on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a research report on Thursday, April 24th. UBS Group boosted their price objective on shares of CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a research report on Friday, April 25th. Erste Group Bank lowered shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Finally, Oppenheimer boosted their price target on CME Group from $269.00 to $279.00 and gave the company an "outperform" rating in a report on Friday, April 11th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $256.80.

Insider Buying and Selling at CME Group

In related news, Director Larry G. Gerdes sold 2,000 shares of the business's stock in a transaction on Thursday, April 24th. The stock was sold at an average price of $264.10, for a total value of $528,200.00. Following the sale, the director now owns 38,651 shares in the company, valued at approximately $10,207,729.10. The trade was a 4.92% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Suzanne Sprague sold 1,500 shares of the firm's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $256.83, for a total value of $385,245.00. Following the transaction, the chief operating officer now owns 8,036 shares of the company's stock, valued at $2,063,885.88. This trade represents a 15.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 24,400 shares of company stock worth $6,533,180 over the last three months. Corporate insiders own 0.30% of the company's stock.

CME Group Stock Down 0.0%

Shares of NASDAQ CME traded down $0.03 during midday trading on Thursday, reaching $285.95. 616,295 shares of the company's stock traded hands, compared to its average volume of 2,181,567. The company has a market cap of $103.04 billion, a price-to-earnings ratio of 29.58, a P/E/G ratio of 6.76 and a beta of 0.45. CME Group Inc. has a one year low of $190.70 and a one year high of $287.05. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The stock's 50 day simple moving average is $269.01 and its 200-day simple moving average is $250.25.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The firm had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.56 billion. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The firm's quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the business posted $2.50 EPS. On average, analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.75%. CME Group's payout ratio is 50.30%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.